Although the mechanism is unknown, Btx-A injection may be an effective, localized, nonsurgical treatment option without addictive properties or systemic side effects for the treatment of ischemic digits. Clinical research supports the safety and efficacy of injection of Btx-A for the treatment of Raynaud phenomenon.



Polls results
1

On a scale of 1 to 10, rate how much this article will change your clinical practice?

NO change
BIG change
75% Article relates to my practice (3/4)
0% Article does not relate to my practice (0/4)
25% Undecided (1/4)
2

Will this article lead to more cost-effective healthcare?

25% Yes (1/4)
75% No (3/4)
0% Undecided (0/4)
3

Was this article biased? (commercial or personal)

0% Yes (0/4)
75% No (3/4)
25% Undecided (1/4)
4

What level of evidence do you think this article is?

0% Level 1 (0/4)
0% Level 2 (0/4)
50% Level 3 (2/4)
25% Level 4 (1/4)
25% Level 5 (1/4)